Diagnostic sensitivity analysis of the immunochemical fecal occult blood test for colorectal cancers

Diagnostic sensitivity analysis of the immunochemical fecal occult blood test for colorectal cancers - FIT STUDY

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009570

Enrollment

500

Registered

2013-04-01

Start date

2014-07-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Immunochemical fecal occult blood test (FIT) using OC sensor io (Eiken co)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preoperative case over 20 years old who has a primary early/ advanced colorectal cancer.

Exclusion criteria

Exclusion criteria: Patient who has synchronous colorectal cancers, IBD and GI cancers.

Design outcomes

Primary

Measure	Time frame
Diagnostic sensitivity of immunochemical fecal occult blood test (FIT) for colorectal cancers based on the location, staging, tumor size and macroscopic types.	—

Secondary

Measure	Time frame
False positive and negative rates of immunochemical fecal occult blood test (FIT) for colorectal cancers based on the location, staging, tumor size and macroscopic types.	—

Countries

Japan

Contacts

Public ContactTakahisa Matsuda

National Cancer Center Hospital, Tokyo, Japan Endoscopy Division

tamatsud@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026